Abstract
We use mathematical modeling via the fast Padé transform (FPT) with respect to a theoretically-designed problem based on time signals that are similar to NMR data as encoded from benign and malignant ovarian cyst fluid. The FPT reconstructed exactly all the input spectral parameters by using exceedingly small fractions of the full time signals both for those corresponding to the benign, as well as to the malignant case. The converged parametric results remained stable thereafter at longer signal lengths. The Padé absorption spectra yielded clear resolution of all the extracted physical metabolites. The capacity of the FPT to resolve and precisely quantify the physical resonances as encountered in benign versus malignant ovarian cystic fluid is demonstrated. The practical significance of such findings is enhanced by the avoidance of the time signals’ exponential tail which is embedded in the background, leading to problems in quantification. Without any fitting or numerical integration of peak areas, the FPT reliably yields the metabolite concentrations of major importance for distinguishing benign from malignant ovarian lesions. Thus, the FPT provides distinct advantages relative to the standard Fourier methodology, which is also stable, but has a number of drawbacks. These include limited resolution capacity, as well as non-parametric estimation, so that only a shape spectrum is generated and post-processing is necessary via, e.g., fitting or numerical integrations which are not unique. The FPT is also distinguished from other competitive parametric methods, which are generally unstable as a function of signal length N at a fixed bandwidth and, therefore, particularly unsuitable to clinical data. We conclude that these advantages of the FPT could be of definite benefit for ovarian cancer diagnostics via NMR and that this line of investigation should continue with encoded data from benign and malignant ovarian tissue, in vitro and in vivo. This avenue is of clinical urgency for early ovarian cancer detection, a goal which is still elusive and achievement of which would confer a major survival benefit.
Similar content being viewed by others
Abbreviations
- Ala:
-
Alanine
- au:
-
Arbitrary units
- Cho:
-
Choline
- COSY:
-
2 dimensional correlated spectroscopy
- Cr:
-
Creatine
- Crn:
-
Creatinine
- C met :
-
Metabolite concentration
- C ref :
-
Reference concentration
- CT:
-
Computerized tomography
- DFT:
-
Discrete Fourier transform
- DLP:
-
Decimated linear predictor
- DPA:
-
Decimated Padé approximant
- DSD:
-
Decimated signal diagonalization
- FFT:
-
Fast Fourier transform
- FID:
-
Free induction decay
- FPT:
-
Fast Padé transform
- Glc:
-
Glucose
- Gln:
-
Glutamine
- Iso:
-
Isoleucine
- HLSVD:
-
Hankel-Lanczos Singular Value Decomposition
- Lac:
-
Lactate
- Lys:
-
Lysine
- Met:
-
Methionine
- MR:
-
Magnetic resonance
- MRI:
-
Magnetic resonance imaging
- MRS:
-
Magnetic resonance spectroscopy
- MRSI:
-
Magnetic resonance spectroscopic imaging
- NMR:
-
Nuclear magnetic resonance
- PA:
-
Padé approximant
- PLCO Trial:
-
Prostate, Lung, Colorectal and Ovarian Trial
- ppm:
-
Parts per million
- SCS:
-
Statistical classification strategy
- SNR:
-
Signal-to-noise ratio
- ST:
-
Shanks transform
- Thr:
-
Threonine
- TVUS:
-
Transvaginal ultrasound
- Val:
-
Valine
References
Dž. Belkić, K. Belkić J. Math. Chem. in press, (2007)
Belkić Dž. (2004) Quantum mechanical signal processing and spectral analysis. Institute of Physics Publishing: Bristol, UK
Belkić Dž., Belkić K. (2005) Phys. Med. Biol. 50: 4385
Bottomley P.A. (1992) . J. Magn. Reson. Imaging 2: 1
Cho Y.-D., Choi G.-H., Lee S.-P., Kim J.-K. (2003) . Magn. Reson. Imaging 21: 663
Opstad K.S., Provencher S.W., Bell B.A., Griffiths J.R., Howe F.A., (2003) . Magn. Reson. Med. 49: 632
Dž. Belkić, Nucl. Instrum. Methods Phys. Res. A 525, 366 (2004)
Pijnappel W.W.F., van den Boogaart A., De Beer R., van Ormondt D. (1992) . J. Magn. Reson. 97: 122
Belkić Dž. (2004) . Nucl. Instrum. Methods Phys. Res. A 525: 372
Belkić Dž. (2006) . Phys. Med. Biol. 51: 2633
Belkić Dž. (2006) . Phys. Med. Biol. 51: 6483
Belkić Dž. (2006) . Adv. Quant. Chem. 51: 157
Belkić Dž., Dando P.A., Taylor H.S. (1999) . J. Main, Chem. Phys. Lett. 315: 135
Belkić Dž., Dando P.A., Main J., Taylor H.S. (2000) . J. Chem. Phys. 113: 6542
Belkić Dž., Dando P.A., Taylor H.S., Main J., Shin S-K. (2000) . J. Phys. Chem. A 104: 11677
Deschamps M., Burghardt I., Derouet C., Bodenhausen G., Belkić Dž. (2000) J. Chem. Phys. 113: 1630
Main J., Dando P.A., Belkić Dž., Taylor H.S. (1999) . Europhys. Lett. 48: 250
Main J., Dando P.A., Belkić Dž., Taylor H.S. (2000) . J. Phys. A 33: 1247
PfeufferJ., Tkáč I., Provencher S.W., Gruetter R. (1999) . J. Magn. Reson. 141: 104
Belkić Dž. (2004) . Nucl. Instrum. Methods Phys. Res. A 525: 379
BelkićDž., Belkić K. (2005) . Int. J. Quantum Chem. 105: 493
Pecorelli S., Favalli G., Zigliani L., Odicino F. (2003) . Int. J. Gynaecol. Obstet. 82: 369
Brewer M.A., Johnson K., Follen M., Gershenson D., Bast R. (2003) . Clin. Cancer Res 9: 20
Runnebaum I.B., Stickeler E. (2001) . J. Cancer Res. Clin. Oncol. 127: 73
Fields M.M., Chevlen E. (2006) . Clin. J. Oncol. Nurs. 10: 77
Bhoola S., Hoskins W.J. (2006) . Obstet. Gynecol. 107: 1399
Einhorn N., Bast R., Knapp R., Nilsson B., Zurawski V., Sjövall K. (2000) . Gynecol. Oncol. 79: 466
Belkić K. (2004) Molecular imaging through magnetic resonance for clinical oncology. Cambridge International Science Publishing, Cambridge, UK
Duffy M.J., Bonfrer J.M., Kulpa J., Rustin G.J., Soletormos G., Torre G.C., et al. (2005) . Int. J. Gynecol. Cancer 15: 679
Garner E.I.O. (2005) . J. Reprod. Med. 50: 447
Kong F., Nicole White C., Xiao X., Feng Y., Xu C., He D., et al. (2006) . Gynecol. Oncol. 100: 247
Liu Y. (2006) . Technol. Cancer Res. Treat. 5: 61
Mor G., Visintin I., Lai Y., Zhao H., Schwartz P., Rutherford T., et al. (2005) . Proc. Natl. Acad. Sci. USA 102: 7677
Rapkiewicz A.V., Espina V., Petricoin E.F., Liotta L.A. (2004) . Eur. J. Cancer 40: 2604
Ransohoff D.F. (2005) . J. Natl. Cancer Inst. 97: 315
Buys S.S., Partridge E., Greene M.H., Prorok P.C., Reding D., Riley T.L. et al. (2005) . Am. J. Obstet. Gynecol. 193: 1630
Taylor K.L., Shelby R., Gelmann E., McGuire C. (2004) . J. Natl. Cancer Inst. 96: 1083
U.S. Preventive Services Task Force, Ann. Fam. Med. 2, 260 (2004)
Imaoka I., Wada A., Kaji Y., Hayashi T., Hayashi M., Matsuo M., Sugimura K. (2006) . Radiographics 26: 1431
Spencer J.A. (2005) . Br. J. Radiol. 78: S94
Kinkel K., Lu Y., Mehdizade A., Pelte M-F., Hricak H. (2005) . Radiology 236: 85
Harlap S., Olson S.H., Barakat R.R., Caputo T.A., Forment S S., Jacobs A.J., et al. (2002) . Ann. Epidemiol. 12: 426
Hill D.A., Preston-Martin S., Ross R.K., Bernstein L. (2002) . Cancer Causes Control 13: 711
Brandão L.A., Domingues R.C. (2004) MR spectroscopy of the brain. Lippincott Williams & Wilkins, Philadelphia, PA
Cho S.W., Cho S.G., Lee J.H., Kim H.-J., Lim M.H., Kim J.H., Suh C.H. (2002) . Korean J. Radiol. 3: 105
Hascalik S., Celik O., Erdem G. (2005) . Int. J. Gynecol. Obstet. 90: 152
Hascalik S., Celik O., Sarak K., Meydanli M.M., Alkan A., Mizrak B. (2005) . Gynecol. Obstet. Invest. 60: 121
Okada T., Harada M., Matsuzaki K., Nishitani H., Aono T.J. (2001) . Magn. Reson. Imaging 13: 912
Smith I.C., Blandford D.E. (1998) . Biochem. Cell. Biol. 76: 472
Wallace J.C., Raaphorst G.P., Somorjai R.L., Ng C.E., Fung Kee Fung M., Senterman M., Smith I.C. (1997) . Magn. Reson. Med. 38: 569
Massuger L.F.A.G., van Vierzen P.B.J., Engelke U., Heerschap A., Wevers R. (1998) . Cancer 82: 1726
Boss E.A., Moolenaar S.H., Massuger L.F., Boonstra H., Engelke U.F., de Jong J.G., Wevers R.A. (2000) . NMR Biomed. 13: 297
Mountford C.E., Doran S., Lean C.L., Russell P.L. (2004) . Chem. Rev. 104: 3677
Gluch L. (2005) . ANZ. J. Surg. 75: 464
Nicholson J.K., Wilson I.D. (1989) . Prog. NMR Spectrosc. 21: 1245
K. Belkić, Nucl. Instrum. Methods Phys. Res. A, in press, (2007)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Belkić, D., Belkić, K. Mathematical modeling of an NMR chemistry problem in ovarian cancer diagnostics. J Math Chem 43, 395–425 (2008). https://doi.org/10.1007/s10910-007-9279-x
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10910-007-9279-x